Profound Medical (PROF) Cost of Revenue (2024 - 2026)

Profound Medical's Cost of Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 95.96% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $5.4 million (up 41.79% YoY), while the FY2025 annual figure was $4.7 million, up 29.15% from the prior year.
• Cost of Revenue was $1.5 million for Q1 2026 at Profound Medical, down from $2.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.0 million in Q4 2025 to a low of $573000.0 in Q1 2024.
• Historically, Cost of Revenue has averaged $1.1 million across 3 years, with a median of $1.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue declined 26.97% in 2025, then soared 95.96% in 2026.
• A 3-year view of Cost of Revenue shows it stood at $1.2 million in 2024, then jumped by 63.59% to $2.0 million in 2025, then fell by 24.22% to $1.5 million in 2026.
• The last three Cost of Revenue figures came in at $1.5 million (Q1 2026), $2.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.